Nanoveu Limited

Nanoveu Limited, a technology company, develops and sells nanotechnology applications for consumer devices in the Americas and internationally. The company provides Nanoshield, an antiviral protector, which is available in various mobile phone screen covers and cases, as well as a commercial film for various surface applications. It also offers EyeFly3D that converts 2D digital displays into 3D without the need for 3D glasses. In addition, the company is developing Customskins vending machines for precisely applying screen covers to mobile phones in just over a minute; EyeFyx, a vision correction solution using hardware and software to manipulate screen output; and anti-flamatory coating technology used in plastic laminates for the aviation and transport sectors. The company was incorporated in 2018 and is based in Subiaco, Australia.

Nanoveu Limited trades as NNVUF on OTC. The company is classified in Technology / Software - Application and reports in USD.

The current profile places the business in Software - Application. This section is intended to summarize the operating segments, products, geographies, and main revenue lines from official filings.

Latest available fiscal data shows $297,464 of revenue and -$7.42M of net income.

Use this area for management strategy, capital allocation priorities, target markets, and measurable goals from the latest annual report or investor presentation.

The app now provides the structure, but exact strategic claims should come from official company documents before being treated as a finished investment thesis.

Nanoveu Limited can be compared against peers such as Avai Bio, Inc., Bambuser AB (publ), DigitalX Limited, Forecastagility Corporation, Investview, Inc., Integrated Research Limited.

A complete thesis should compare growth, margins, balance-sheet risk, valuation multiples, and market position against direct competitors.

Current signals to investigate include market capitalization of $48.62M, beta of 0.54, and return on equity of -60.3%.

This section should be validated with evidence such as durable margins, brand strength, regulation, switching costs, cost advantage, distribution, or technology.

Key risks should include financial leverage, cyclicality, customer concentration, regulatory exposure, currency risk, and execution risk.

NNVUF currently shows total debt of $341,824 and beta of 0.54. Missing data should be treated as a research gap, not as low risk.

Production-capacity detail is not available as structured data yet. For industrial, defense, semiconductor, or real-estate companies, this should be reviewed from annual reports and investor presentations.

No structured backlog field is available yet. If the company reports backlog, review the relevant filing section before adding it to the thesis.

Use this section for major contracts, product launches, construction projects, acquisitions, or strategic programs that can materially affect valuation.

No recent SEC-style filings are available for this symbol yet.

Customer concentration is not available as structured data here. Add it from official filings when a company discloses material customers or revenue concentration.

Supplier concentration and critical supply-chain dependencies are not available as structured data here. This should be researched from annual reports and risk disclosures.

Company website: https://nanoveu.com

For US-listed stocks, verify the thesis against official filings, earnings call transcripts, and company investor relations materials.